Safety of nevirapine compared to abacavir on a background of zidovudine/lamivudine as first-line antiretroviral therapy: a randomised double-blind trial conducted in Uganda.

From:
Foreign, Commonwealth & Development Office
Published
1 January 2006
Country:
Uganda
Document Type:
Research Paper
Theme:
Health
First published:
1 January 2006
Authors:
Munderi, P.

Citation

13th Conference on Retroviruses and Opportunistic Infections, Denver, USA, 5-9 February 2006: Abstract 109LB.

Safety of nevirapine compared to abacavir on a background of zidovudine/lamivudine as first-line antiretroviral therapy: a randomised double-blind trial conducted in Uganda.

Updates to this page

Published 1 January 2006
Contents